Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.

PURPOSE The purpose of this study was to assess the presence of tumor hypoxia using two independent techniques: binding of the 2-nitroimidazole EF5 and Eppendorf needle electrode measurements. The distribution of tumor hypoxia was assessed with respect to tumor necrosis in corresponding histological studies. METHODS AND MATERIALS Each of several rats bearing a subcutaneous 9L glioma or Morris 7777 hepatoma tumor was given EF5 i.v. to a final, whole-body concentration of 100 microM. About 2.5 h later, each rat was anesthetized, and needle electrode measurements were made in the tumor along 1-5 tracks (30-200 individual measurements). At 3 h post-EF5 injection, the tumor was excised and frozen. Frozen sections were analyzed for the presence and distribution of binding of EF5 and necrosis using immunohistochemical techniques followed by staining with hematoxylin and eosin (H&E). The histochemical analysis and electrode readings in similar regions of the tumor were compared. RESULTS Electrode measurements were taken at 0.4-mm intervals along one-dimensional tracks, whereas EF5 binding measurements from tissue sections contained two-dimensional information at high spatial resolution ( approximately 2.5 micro). The EF5 measurements showed greater spatial heterogeneity than did the electrode measurements. In tumor regions with minimal necrosis, needle tracks with relatively high pO(2) readings were usually found to contain relatively low EF5 binding, and vice versa. Because EF5 binding is inversely related to tissue pO(2), this result was expected. The expected inverse correlation of the two techniques was most disparate in necrotic tumor regions (confirmed by H&E staining), where needle electrode measurements showed low to zero pO(2) values, but little or no EF5 binding was found. CONCLUSION The two methods compared in this study operate in fundamentally different ways and provide substantially different information. EF5 binding provided detailed spatial information on the distribution of hypoxia in viable tumor tissue. There was no EF5 binding in necrotic tumor tissue because cells in such tissue were unable to metabolize the drug. In contrast, output from the needle electrode method appeared to represent a "track-average" tissue pO(2) and did not distinguish between extreme hypoxia and either macroscopic or microscopic necrosis. At the present time, the importance of tumor necrosis in determining treatment response is unknown. However, our data suggest that the Eppendorf needle electrode technique will overestimate the presence of hypoxia. Both techniques are potentially limited by sampling errors in tumors with heterogeneous distributions of hypoxia.

[1]  J. Overgaard,et al.  The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. , 1995, Acta oncologica.

[2]  C. Koch,et al.  Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. , 1995, British Journal of Cancer.

[3]  B. Fish,et al.  Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines. , 1995, Radiation research.

[4]  A. Alavi,et al.  Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  C. Koch,et al.  Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. , 1996, International journal of radiation oncology, biology, physics.

[6]  J. Leith,et al.  Cellular radiosensitivity of a rat brain tumor , 1975, Cancer.

[7]  D. Hedley,et al.  Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. , 1998, International journal of radiation oncology, biology, physics.

[8]  C. Grau,et al.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. , 1994, International journal of radiation oncology, biology, physics.

[9]  Susan M. Chang,et al.  Necrosis as a prognostic factor in glioblastoma multiforme , 1996, Cancer.

[10]  D. Hirst,et al.  Changes in misonidazole binding with hypoxic fraction in mouse tumors. , 1985, International journal of radiation oncology, biology, physics.

[11]  C. Koch,et al.  Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.

[12]  T. L. James,et al.  Correlations between in vivo 31P MRS measurements, tumor size, cell survival, and hypoxic fraction in the murine EMT6 tumor , 1992, Magnetic resonance in medicine.

[13]  P. Olive,et al.  Hypoxic fractions measured in murine tumors and normal tissues using the comet assay. , 1994, International journal of radiation oncology, biology, physics.

[14]  T. Cremer,et al.  Laser microirradiation of Chinese hamster cells at wavelength 365 nm: effects of psoralen and caffeine. , 1981, Radiation research.

[15]  M. Fernö,et al.  Urokinase‐plasminogen‐activator levels and prognosis in 69 soft‐tissue sarcomas , 1996, International journal of cancer.

[16]  T W Griffin,et al.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.

[17]  S. Patchett,et al.  Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death , 1997, Diseases of the colon and rectum.

[18]  M. Dewhirst,et al.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.

[19]  J. Overgaard,et al.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[21]  R. Gray,et al.  Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Morris Studies on the development, biochemistry, and biology of experimental hepatomas. , 1965, Advances in cancer research.

[23]  D. Neuberg,et al.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  L. Harwell,et al.  Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. , 1993, Cancer research.

[25]  R. Hill,et al.  Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay. , 1996, Radiation research.

[26]  C. Koch,et al.  Radiolytic reduction of protein and nonprotein disulfides in the presence of formate: a chain reaction. , 1991, Archives of biochemistry and biophysics.

[27]  A. Fyles,et al.  Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  S M Evans,et al.  Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker , 1997, Journal of surgical oncology.

[29]  S. Michaelson,et al.  Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. , 1980, Radiation research.

[30]  J. Raleigh,et al.  Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy. , 1990, International journal of radiation biology.

[31]  B. Gasser,et al.  Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. , 1996, The Annals of thoracic surgery.

[32]  C. Sehgal,et al.  Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia. , 1997, British Journal of Cancer.

[33]  G. Rosner,et al.  Quantification of CCI-103F labeling heterogeneity in canine solid tumors. , 1997, International journal of radiation oncology, biology, physics.

[34]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[35]  C. Koch,et al.  2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. , 1996, Cancer research.

[36]  L. Golberg,et al.  Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. , 1992, British Journal of Cancer.

[37]  J. Sham,et al.  Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: Incidence and prognostic significance , 1997, Head & neck.

[38]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[39]  T L Phillips,et al.  Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.

[40]  R. Hill,et al.  Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques. , 1995, Radiation research.

[41]  J. Griffiths,et al.  Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. , 1997, Cancer research.

[42]  S. R. Parker,et al.  Cyanine dye labeling reagents--carboxymethylindocyanine succinimidyl esters. , 1990, Cytometry.

[43]  C. Koch,et al.  Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. , 1996, The Journal of pharmacology and experimental therapeutics.

[44]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[45]  P Vaupel,et al.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  C. Koch,et al.  Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts , 1996, International journal of cancer.